HMG stands for human menopausal gonadotropin, also called menotropins. It supplies follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activity. The search term “HMG peptide” refers to this glycoprotein preparation. [1]
Prescription menotropins have a clinical role in fertility treatment. A research vial with the same ingredient name doesn’t necessarily match the approved medicine’s contents, quality or instructions.
What does HMG do?
Menopur, a prescription hMG product, is purified from the urine of postmenopausal women. Its US indication is follicle development and pregnancy in ovulatory women undergoing assisted reproductive technology. [1]
It helps to separate three names that frequently appear together in fertility discussions. They are related, but they are not interchangeable.
| Name | What it provides | Why the distinction matters |
|---|---|---|
| HMG / menotropins | FSH and LH activity | A combined gonadotropin preparation used in ovarian stimulation. [1] |
| hCG | Human chorionic gonadotropin, with LH-like activity | Can serve a different role, such as an ovulation trigger or support for testosterone production in selected men. It does not simply replace the FSH component. [2][3] |
| Recombinant FSH | FSH produced using recombinant technology | An alternative stimulation medicine compared with highly purified hMG in clinical trials. [4] |
What benefits are supported by fertility research?
The useful question is not whether hMG “works better” in every situation. It is whether a particular preparation performs well for a defined fertility treatment and outcome.
In a randomized trial of 749 women undergoing an antagonist IVF protocol with planned single-blastocyst transfer, ongoing pregnancy after the fresh cycle occurred in 29% with highly purified hMG and 27% with recombinant FSH. The trial established noninferiority: hMG met the study’s criterion for not being meaningfully worse. It did not establish superiority. Cumulative live-birth rates, including frozen transfers within a year, were 40% and 38%. [4]
A separate pooled analysis of two trials involved 986 women using a different, long GnRH-agonist IVF approach. Live births were reported in 26.5% of the hMG group and 20.8% of the recombinant-FSH group, a statistically significant difference in that analysis. [5]
These findings are not contradictory promises to patients. Treatment settings differ. A rate from one trial cannot be used as an individual’s chance of pregnancy, and a favorable comparison does not make one drug the best choice for every fertility diagnosis.
HMG for men: diagnosis comes first
Gonadotropin treatment can help selected men with hypogonadotropic hypogonadism, where inadequate hormonal signaling affects testicular function. The AUA/ASRM guideline describes specialist treatment using hCG, with FSH or an FSH analogue added when appropriate to support sperm production, also called spermatogenesis. Hormone response and the underlying cause guide the plan. [3]
That is not the same as prescribing hMG for every abnormal semen analysis, low-libido complaint or low testosterone result. Menopur’s US indication described above is for women undergoing assisted reproduction. A discussion of male gonadotropin therapy should not be read as a claim that every hMG product is approved for that use.
If fertility is the goal, ask which diagnosis is being treated and how success will be measured. A change in testosterone alone does not answer whether sperm production or the chance of conception has improved.
What does 75 IU mean?
International units describe biological activity, not a universal weight conversion. A Menopur vial labeled 75 IU contains 75 IU of FSH activity and 75 IU of LH activity. Adding those numbers does not make it a vial with 150 IU of FSH. [1]
Syringe markings are a separate measurement. On a U-100 insulin syringe, 100 markings correspond to 1 mL of liquid. They do not identify the hMG activity in that liquid. You need the exact product and prepared concentration to interpret a volume, and correct arithmetic still does not determine an appropriate treatment dose.
Do not assume that an online milligram label can be converted to IU using a single rule for all hMG preparations. Bring an unclear label or conflicting set of instructions to the prescribing clinic or pharmacist.
Related dosage pages: For vial-specific concentration, reconstitution, and measurement examples, see HMG (0.15 mg / 75 IU Vial) Dosage Protocol. Each linked protocol remains a separate reference because vial strength changes concentration and syringe-unit calculations.
Side effects and symptoms that need attention
Reported effects of menotropins include headache, stomach cramping, dizziness and breast tenderness. Tell the care team about persistent or troublesome symptoms. [6]
A more serious concern is ovarian hyperstimulation syndrome (OHSS), an excessive response to fertility stimulation. Severe abdominal or pelvic pain, marked swelling, reduced urination or trouble breathing need prompt medical assessment. Breathing difficulty, chest pain, fainting or signs of a severe allergic reaction warrant emergency help. [2][6]
Monitoring is part of the treatment, not an optional extra. ASRM guidance emphasizes assessing ovarian-response risk and individualizing the stimulation plan. Ultrasound findings, laboratory results and previous responses help clinicians decide whether to continue, adjust or change an approach. [7]
Preparation and storage are product-specific
Do not transfer generic peptide-mixing instructions to a prescription fertility product. Menopur’s label specifies its diluent and says to use the solution immediately after reconstitution, discarding unused material. That is not a multiweek storage instruction for a mixed vial. [1]
The pharmacy or fertility team should demonstrate the preparation and explain the prescribed schedule. If a dose is missed, contact that team for instructions rather than improvising an extra injection.
Questions to take to a fertility appointment
- What diagnosis and treatment goal does this medicine address?
- Why is this preparation being chosen instead of another gonadotropin?
- Which scans or blood tests will guide adjustments?
- Which symptoms mean I should call the clinic or seek emergency care?
- What are the exact product’s mixing, storage and missed-dose instructions?
Common questions
Is HMG the same as HGH?
No. The similar initials cause confusion. HMG refers to reproductive gonadotropins; HGH means human growth hormone. An article about growth hormone does not establish benefits or instructions for menotropins.
How long does HMG take to work?
There is no single timeline that covers ovarian stimulation and male infertility. The relevant endpoint may be follicle development, semen findings or pregnancy. Ask about the expected monitoring milestones for your diagnosis instead of borrowing a cycle length from a different use.
Is a research vial equivalent to Menopur?
Do not assume equivalence. A shared ingredient name is not proof of matching manufacturing controls, biological activity or clinical instructions. A certificate describing a laboratory sample cannot substitute for a prescription product’s approval and labeling.
The bottom line
HMG has a real place in fertility medicine. Understanding its FSH and LH activity, the reason it is being used and the monitoring plan is more useful than a universal dosage chart. A reproductive specialist can explain which findings apply to your situation.
Related dosage protocols and research
Explore related research, dosage references and guides below. Vial strengths have separate references because concentration and syringe-unit calculations differ. A comparison does not mean the compounds are interchangeable.
Matching dosage protocols
Further research context
References
- DailyMed. Menopur (menotropins) prescribing information.
- Mayo Clinic. Follicle-stimulating hormone and luteinizing hormone: medication information.
- AUA/ASRM. Diagnosis and treatment of infertility in men, guideline part II.
- Randomized comparison of highly purified hMG and recombinant FSH in a GnRH-antagonist IVF protocol, 2012.
- Highly purified hMG versus recombinant FSH: pooled analysis of randomized IVF trials, 2008.
- Cleveland Clinic. Menotropins injection.
- ASRM. Prevention of moderate and severe ovarian hyperstimulation syndrome, guideline.